Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience. [electronic resource]
Producer: 20111024Description: 1041-8 p. digitalISSN:- 1029-2403
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Lymphoma, Extranodal NK-T-Cell -- drug therapy
- Male
- Middle Aged
- Nausea -- chemically induced
- Neutropenia -- chemically induced
- Nose Neoplasms -- drug therapy
- Prednisone -- administration & dosage
- Survival Analysis
- Thrombocytopenia -- chemically induced
- Time Factors
- Treatment Outcome
- Vincristine -- administration & dosage
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.